Report Title | Price | Action |
---|---|---|
Sphingosine 1-Phosphate Receptor 5 (Endothelial Differentiation G Protein Coupled Receptor 8 or Sphingosine 1 Phosphate Receptor Edg 8 or S1PR5) - Drugs in Development, 2021
Sphingosine 1-Phosphate Receptor 5 (Endothelial Differentiation G Protein Coupled Receptor 8 or Sphingosine 1 Phosphate Receptor Edg 8 or S1PR5) - Dru...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
Ubiquitin Like Modifier Activating Enzyme 1 (Ubiquitin Activating Enzyme E1 or Protein A1S9 or UBA1 or EC 6.3.2.19 or EC 6.2.1.45) - Drugs in Development, 2021
Ubiquitin Like Modifier Activating Enzyme 1 (Ubiquitin Activating Enzyme E1 or Protein A1S9 or UBA1 or EC 6.3.2.19 or EC 6.2.1.45) - Drugs in Developm...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
Blood Coagulation (Hematological Disorders) - Drugs in Development, 2021
Blood Coagulation (Hematological Disorders) - Drugs in Development, 2021 Summary Blood Coagulation (Hematological Disorders) - Drugs in Development,...
Published: Apr-2021 | No. of Pages: 40
|
$ 2000 | |
Uterine Cancer (Oncology) - Drugs in Development, 2021
Uterine Cancer (Oncology) - Drugs in Development, 2021 Summary Uterine Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Ut...
Published: Apr-2021 | No. of Pages: 110
|
$ 2000 | |
Metastatic Melanoma (Oncology) - Drugs in Development, 2021
Metastatic Melanoma (Oncology) - Drugs in Development, 2021 Summary Metastatic Melanoma (Oncology) - Drugs in Development, 2021 provides an overview...
Published: Apr-2021 | No. of Pages: 425
|
$ 2500 | |
Ubiquitin Carboxyl Terminal Hydrolase 7 (Deubiquitinating Enzyme 7 or Ubiquitin Thioesterase 7 or Herpesvirus Associated Ubiquitin Specific Protease or Ubiquitin Specific Processing Protease 7 or USP7 or EC 3.4.19.12) - Drugs in Development, 2021
Ubiquitin Carboxyl Terminal Hydrolase 7 (Deubiquitinating Enzyme 7 or Ubiquitin Thioesterase 7 or Herpesvirus Associated Ubiquitin Specific Protease o...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
Utrophin (Dystrophin Related Protein 1 or DRP1 or UTRN) - Drugs in Development, 2021
Utrophin (Dystrophin Related Protein 1 or DRP1 or UTRN) - Drugs in Development, 2021 Summary Utrophin (Dystrophin Related Protein 1 or DRP1 or UTRN)...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
Lupus Erythematosus (Immunology) - Drugs in Development, 2021
Lupus Erythematosus (Immunology) - Drugs in Development, 2021 Summary Lupus Erythematosus (Immunology) - Drugs in Development, 2021 provides an over...
Published: Apr-2021 | No. of Pages: 40
|
$ 2000 | |
Atrophic Vaginitis (Vaginal Atrophy/Vulvovaginal Atrophy/Urogenital Atrophy) (Women's Health) - Drugs in Development, 2021
Atrophic Vaginitis (Vaginal Atrophy/Vulvovaginal Atrophy/Urogenital Atrophy) (Women's Health) - Drugs in Development, 2021 Summary Atrophic Vaginiti...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
Metastatic Ovarian Cancer (Oncology) - Drugs in Development, 2021
Metastatic Ovarian Cancer (Oncology) - Drugs in Development, 2021 Summary Metastatic Ovarian Cancer (Oncology) - Drugs in Development, 2021 provides...
Published: Apr-2021 | No. of Pages: 115
|
$ 2000 | |
Acquired (Autoimmune) Hemolytic Anemia (Hematological Disorders) - Drugs in Development, 2021
Acquired (Autoimmune) Hemolytic Anemia (Hematological Disorders) - Drugs in Development, 2021 Summary Acquired (Autoimmune) Hemolytic Anemia (Hemato...
Published: Apr-2021 | No. of Pages: 50
|
$ 2000 | |
Usherin (Usher Syndrome Type 2A Protein or USH2A) - Drugs in Development, 2021
Usherin (Usher Syndrome Type 2A Protein or USH2A) - Drugs in Development, 2021 Summary Usherin (Usher Syndrome Type 2A Protein or USH2A) - Drugs in ...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
Vascular Endothelial Growth Factor C (Flt4 Ligand or Vascular Endothelial Growth Factor Related Protein or VEGFC) - Drugs in Development, 2021
Vascular Endothelial Growth Factor C (Flt4 Ligand or Vascular Endothelial Growth Factor Related Protein or VEGFC) - Drugs in Development, 2021 Summar...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
Facioscapulohumeral Muscular Dystrophy (FSHD) (Musculoskeletal Disorders) - Drugs in Development, 2021
Facioscapulohumeral Muscular Dystrophy (FSHD) (Musculoskeletal Disorders) - Drugs in Development, 2021 Summary Facioscapulohumeral Muscular Dystroph...
Published: Apr-2021 | No. of Pages: 40
|
$ 2000 | |
Varicella Zoster (HHV-3) Infections (Infectious Disease) - Drugs in Development, 2021
Varicella Zoster (HHV-3) Infections (Infectious Disease) - Drugs in Development, 2021 Summary Varicella Zoster (HHV-3) Infections (Infectious Diseas...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
Metastatic Pancreatic Cancer (Oncology) - Drugs in Development, 2021
Metastatic Pancreatic Cancer (Oncology) - Drugs in Development, 2021 Summary Metastatic Pancreatic Cancer (Oncology) - Drugs in Development, 2021 pr...
Published: Apr-2021 | No. of Pages: 160
|
$ 2000 | |
Acute Coronary Syndrome (Cardiovascular) - Drugs in Development, 2021
Acute Coronary Syndrome (Cardiovascular) - Drugs in Development, 2021 Summary Acute Coronary Syndrome (Cardiovascular) - Drugs in Development, 2021 ...
Published: Apr-2021 | No. of Pages: 50
|
$ 2000 | |
Voltage Dependent T Type Calcium Channel Subunit Alpha 1H (Voltage Gated Calcium Channel Subunit Alpha Cav3.2 or CACNA1H) - Drugs in Development, 2021
Voltage Dependent T Type Calcium Channel Subunit Alpha 1H (Voltage Gated Calcium Channel Subunit Alpha Cav3.2 or CACNA1H) - Drugs in Development, 2021...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
Vascular Endothelial Growth Factor D (c Fos Induced Growth Factor or VEGFD or FIGF) - Drugs in Development, 2021
Vascular Endothelial Growth Factor D (c Fos Induced Growth Factor or VEGFD or FIGF) - Drugs in Development, 2021 Summary Vascular Endothelial Growth...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
Gynecological Cancer (Oncology) - Drugs in Development, 2021
Gynecological Cancer (Oncology) - Drugs in Development, 2021 Summary Gynecological Cancer (Oncology) - Drugs in Development, 2021 provides an overvi...
Published: Apr-2021 | No. of Pages: 40
|
$ 2000 |